{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:40:42Z","timestamp":1784882442975,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T00:00:00Z","timestamp":1506384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Funda\u00e7\u00e3o de Aux\u00edlio \u00e0 Pesquisa do Estado de S\u00e3o Paulo","award":["96\/2222-3"],"award-info":[{"award-number":["96\/2222-3"]}]},{"name":"Funda\u00e7\u00e3o de Aux\u00edlio \u00e0 Pesquisa do Estado de S\u00e3o Paulo \u2013 Centro de Pesquisa, Inova\u00e7\u00e3o e Difus\u00e3o"},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico - Instituto Nacional de Ci\u00eancia e Tecnologia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12630-017-0978-x","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T19:36:30Z","timestamp":1506454590000},"page":"1202-1210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Idiopathic hyperCKemia and malignant hyperthermia susceptibility","HyperCK\u00e9mie idiopathique et susceptibilit\u00e9 \u00e0 l\u2019hyperthermie maligne"],"prefix":"10.1007","volume":"64","author":[{"given":"Joilson M.","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela V.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Galleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariz","family":"Vainzof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia F. R.","family":"Sobreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beny","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acary S. B.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L. G.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga C. A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","first-page":"17790","DOI":"10.1074\/jbc.272.28.17790","volume":"272","author":"BB Roman","year":"1997","unstructured":"Roman BB, Wieringa B, Koretsky AP. Functional equivalence of creatine kinase isoforms in mouse skeletal muscle. J Biol Chem 1997; 272: 17790-4.","journal-title":"J Biol Chem"},{"key":"978_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.nmd.2014.05.005","volume":"24","author":"R Zutt","year":"2014","unstructured":"Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJ, deVisser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord 2014; 24: 651-9.","journal-title":"Neuromuscul Disord"},{"key":"978_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","volume":"17","author":"T Kyriakides","year":"2010","unstructured":"Kyriakides T, Angelini C, Schaefer J, European Federation of Neurological Societies, et al. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol 2010; 17: 767-73.","journal-title":"Eur J Neurol"},{"key":"978_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s004150200010","volume":"249","author":"A Prelle","year":"2002","unstructured":"Prelle A, Tancredi L, Sciacco M, et al. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol 2002; 249: 305-11.","journal-title":"J Neurol"},{"key":"978_CR5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1213\/00000539-199705000-00016","volume":"84","author":"MR Weglinski","year":"1997","unstructured":"Weglinski MR, Wedel DJ, Engel AG. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg 1997; 84: 1038-41.","journal-title":"Anesth Analg"},{"key":"978_CR6","doi-asserted-by":"crossref","unstructured":"Almeida da Silva HC, dos Santos Almeida C, Mendes Brand\u00e3o JC, et al. Malignant hyperthermia in Brazil: analysis of hotline activity in 2009. Braz J Anesthesiol 2013; 63: 13-9.","DOI":"10.1016\/S0034-7094(13)70195-8"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/bja\/aev225","volume":"115","author":"PM Hopkins","year":"2015","unstructured":"Hopkins PM, R\u00fcffert H, Snoeck MM, European Malignant Hyperthermia Group, et al. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth 2015; 115: 531-9.","journal-title":"Br J Anaesth"},{"key":"978_CR8","first-page":"301","volume":"29","author":"L Thomas","year":"2005","unstructured":"Thomas L, Muller M, Schumann G, et al. Consensus of DGKL and VDGH for interim reference intervals on enzymes in serum. J Lab Med 2005; 29: 301-8.","journal-title":"J Lab Med"},{"key":"978_CR9","volume-title":"Muscle Biopsy: a Practical Approach","author":"V Dubowitz","year":"1985","unstructured":"Dubowitz V. Muscle Biopsy: a Practical Approach. 2nd ed. London: Bailli\u00e8re Tindal; 1985 .","edition":"2"},{"key":"978_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.","journal-title":"J Biol Chem"},{"key":"978_CR11","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1212\/WNL.48.5.1238","volume":"48","author":"C Sobreira","year":"1997","unstructured":"Sobreira C, Hirano M, Shanske S, et al. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 1997; 48: 1238-43.","journal-title":"Neurology"},{"key":"978_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1006\/bmmb.1994.1004","volume":"51","author":"MA Birch-Machin","year":"1994","unstructured":"Birch-Machin MA, Briggs HL, Saborido AA, Bindoff LA, Turnbull DM. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol 1994; 51: 35-42.","journal-title":"Biochem Med Metab Biol"},{"key":"978_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23220","author":"MS Naslavsky","year":"2017","unstructured":"Naslavsky MS, Yamamoto GL, Ferreira de Almeida T, et al. Exomic variants of an elderly cohort of Brazilians in the ABraOM database. Hum Mutat 2017. DOI: 10.1002\/humu.23220 .","journal-title":"Hum Mutat"},{"key":"978_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","volume":"23","author":"N Dlamini","year":"2013","unstructured":"Dlamini N, Voermans NC, Lillis S, et al. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. Neuromuscul Disord 2013; 23: 540-8.","journal-title":"Neuromuscul Disord"},{"key":"978_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/ALN.0b013e3181862a0d","volume":"109","author":"A Malandrini","year":"2008","unstructured":"Malandrini A, Orrico A, Gaudiano C, et al. Muscle biopsy and in vitro contracture test in subjects with idiopathic hyperCKemia. Anesthesiology 2008; 109: 625-8.","journal-title":"Anesthesiology"},{"key":"978_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/mus.23755","volume":"47","author":"NJ Silvestri","year":"2013","unstructured":"Silvestri NJ, Wolfe GI. Asymptomatic\/pauci-symptomatic creatine kinase elevations (hyperckemia). Muscle Nerve 2013; 47: 805-15.","journal-title":"Muscle Nerve"},{"key":"978_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jns.2015.06.035","volume":"356","author":"K Sano","year":"2015","unstructured":"Sano K, Miura S, Fujiwara T, et al. A novel missense mutation of RYR1 in familial idiopathic hyper CK-emia. J Neurol Sci 2015; 356: 142-7.","journal-title":"J Neurol Sci"},{"key":"978_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ymgme.2011.07.001","volume":"104","author":"GD Vladutiu","year":"2011","unstructured":"Vladutiu GD, Isackson PJ, Kaufman K, et al. Genetic risk for malignant hyperthermia in non-anesthesia-induced myopathies. Mol Genet Metab 2011; 104: 167-73.","journal-title":"Mol Genet Metab"},{"key":"978_CR19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/ALN.0000000000000732","volume":"123","author":"MA Timmins","year":"2015","unstructured":"Timmins MA, Rosenberg H, Larach MG, Sterling C, Kraeva N, Riazi S. Malignant hyperthermia testing in probands without adverse anesthetic reaction. Anesthesiology 2015; 123: 548-56.","journal-title":"Anesthesiology"},{"key":"978_CR20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1399-0004.2009.01251.x","volume":"76","author":"N Sambuughin","year":"2009","unstructured":"Sambuughin N, Capacchione J, Blokhin A, Bayarsaikhan M, Bina S, Muldoon S. The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility. Clin Genet 2009; 76: 564-8.","journal-title":"Clin Genet"},{"key":"978_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/ALN.0b013e318167aee2","volume":"108","author":"MG Larach","year":"2008","unstructured":"Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB. Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States. Anesthesiology 2008; 108: 603-11.","journal-title":"Anesthesiology"},{"key":"978_CR22","first-page":"409","volume":"28","author":"H Rueffert","year":"2009","unstructured":"Rueffert H, Wehner M, Ogunlade V, Meinecke C, Schober R. Mild clinical and histopathological features in patients who carry the frequent and causative malignant hyperthermia RyR1 mutation p.Thr2206Met. Clin Neuropathol 2009; 28: 409-16.","journal-title":"Clin Neuropathol"},{"key":"978_CR23","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1046\/j.1432-1327.2000.01566.x","volume":"267","author":"DH MacLennan","year":"2000","unstructured":"MacLennan DH. Ca2+ signalling and muscle disease. Eur J Biochem 2000; 267: 5291-7.","journal-title":"Eur J Biochem"},{"key":"978_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ahj.2007.06.008","volume":"154","author":"LM Brewster","year":"2007","unstructured":"Brewster LM, Mairuhu G, Sturk A, van Montfrans GA. Distribution of creatine kinase in the general population: implications for statin therapy. Am Heart J 2007; 154: 655-61.","journal-title":"Am Heart J"},{"key":"978_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/ajhb.22335","volume":"25","author":"L Kimura","year":"2013","unstructured":"Kimura L, Ribeiro-Rodrigues EM, De Mello Auricchio MT, Vicente JP, Batista Santos SE, Mingroni-Netto RC. Genomic ancestry of rural African-derived populations from Southeastern\u00a0Brazil. Am J Hum Biol 2013; 25: 35-41.","journal-title":"Am J Hum Biol"},{"key":"978_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5007\/1980-0037.2014v16n2p129","volume":"16","author":"DB Coelho","year":"2014","unstructured":"Coelho DB, Morandi RF, Melo MA, Andrade RL, da Paix\u00e3o RC, Silami-Garcia E. Analysis of the trends of creatine kinase levels during the preseason of a professional soccer team. Rev Bras Cineantropom Desempenho Hum 2014; 16: 129-35.","journal-title":"Rev Bras Cineantropom Desempenho Hum"},{"key":"978_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<575::AID-MUS17>3.0.CO;2-5","volume":"23","author":"JC Reijneveld","year":"2000","unstructured":"Reijneveld JC, Notermans NC, Linssen WH, Wokke JH. Benign prognosis in idiopathic hyper-CK-emia. Muscle Nerve 2000; 23: 575-9.","journal-title":"Muscle Nerve"},{"key":"978_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","volume":"118","author":"S Riazi","year":"2014","unstructured":"Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg 2014; 118: 381-7.","journal-title":"Anesth Analg"},{"key":"978_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1399-6576.2007.01293.x","volume":"51","author":"G Islander","year":"2007","unstructured":"Islander G, Rydenfelt K, Ranklev E, Bodelsson M. Male preponderance of patients testing positive for malignant hyperthermia susceptibility. Acta Anaesthesiol Scand 2007; 51: 614-20.","journal-title":"Acta Anaesthesiol Scand"},{"key":"978_CR30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/ene.12713","volume":"22","author":"M Snoeck","year":"2015","unstructured":"Snoeck M, Engelen BGM, K\u00fcsters B, et al. RYR1-related myopathies: a wide spectrum of phenotypes throughout life. Eur J Neurol 2015; 22: 1094-112.","journal-title":"Eur J Neurol"},{"key":"978_CR31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1212\/WNL.34.4.544","volume":"4","author":"N Sunohara","year":"1984","unstructured":"Sunohara N, Takagi A, Nonaka I, Sugita H, Satoyoshi E. Idiopathic hyperCKemia. Neurology 1984; 4: 544-7.","journal-title":"Neurology"},{"key":"978_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/194296","author":"PM Kasi","year":"2011","unstructured":"Kasi PM. Malignant hyperthermia and idiopathic hyperCKemia. Case Rep Med 2011. DOI: 10.1155\/2011\/194296 .","journal-title":"Case Rep Med"},{"key":"978_CR33","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1212\/01.wnl.0000324929.33780.2f","volume":"71","author":"CE D\u2019Arcy","year":"2008","unstructured":"D\u2019Arcy CE, Bjorksten A, Yiu EM, et al. King-denborough syndrome caused by a novel mutation in the ryanodine receptor gene. Neurology 2008; 71: 776-7.","journal-title":"Neurology"},{"key":"978_CR34","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s12630-013-0005-9","volume":"60","author":"D Orlov","year":"2013","unstructured":"Orlov D, Keith J, Rosen D, Croul S, Kraeva N, Riazi S. Analysis of histomorphology in malignant hyperthermia-susceptible patients. Can J Anesth 2013; 60: 982-9.","journal-title":"Can J Anesth"},{"key":"978_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/bja\/79.3.327","volume":"79","author":"P Mezin","year":"1997","unstructured":"Mezin P, Payen JF, Bosson JL, Brambilla E, Stieglitz P. Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies. Br J Anaesth 1997; 79: 327-31.","journal-title":"Br J Anaesth"},{"key":"978_CR36","first-page":"1129","volume-title":"malignant hyperthermia","author":"G Kozak-Ribbens","year":"1994","unstructured":"Kozak-Ribbens G. Mitochondrial disordens in malignant hyperthermia. In: Moro M, Kikuchi H, Yuge O, editors. malignant hyperthermia. Tokyo: Springer; 1994. p. 1129-36."},{"key":"978_CR37","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1096\/fj.11-197582","volume":"26","author":"B Yuen","year":"2012","unstructured":"Yuen B, Boncompagni S, Feng W, et al. Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage. FASEB J 2012; 26: 1311-22.","journal-title":"FASEB J"},{"key":"978_CR38","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"R Robinson","year":"2006","unstructured":"Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006; 27: 977-89.","journal-title":"Hum Mutat"},{"key":"978_CR39","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/humu.20878","volume":"30","author":"S Levano","year":"2009","unstructured":"Levano S, Vukcevic M, Singer M, et al. Increasing the number of diagnostic mutations in malignant hyperthermia. Hum Mutat 2009; 30: 590-8.","journal-title":"Hum Mutat"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12630-017-0978-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-017-0978-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-017-0978-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T13:43:25Z","timestamp":1659534205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12630-017-0978-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s12630-017-0978-x","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,26]]}}}